Health Care Price Certainty for All Americans Act

S. 2120--Older Americans Act Reauthorization Act of 2025--Reauthorizes through FY2030, modifies, and establishes programs under the Older Americans Act, which supports social services and activities for individuals aged 60 years or older. S.1105--No Unreasonable Payments, Coding, or Diagnoses for the Elderly (No UPCODE) Act--An act to improve the way Medicare Advantage plans assess patients health risks and reduce overpayments for care. H.R 4093--Apples to Apples--An act to require the Secretary of Health and Human Services to publish information on expenditures under the Medicare program, and for other purposes. S. 2625--Independent BROKERS TIME Act of 2025--An Act to carry out certain activities relating to the regulation of independent agents and brokers and third-party marketing organizations under parts C and D of the Medicare program, and for other purposes. H.R 5243--Increase data transparency for supplemental benefits under Medicare Advantage--An Act to increase data transparency around Medicare Advantage supplemental benefits for seniors. S. 2793--Require Medicare Advantage plans to cover items and services furnished by certain essential community providers within a service area--An act to add an Essential Community Provider (ECP) requirement to Medicare Advantage networks. H.R. 5454--Medicare Advantage Prompt Pay Act--An act to improve Medicare Advantages (MA) billing practices, offer certainty health care providers who contract with MA plans, and ensure that seniors arent stuck with unfair, confusing, or delayed bills after receiving critical care. HR 5746--Addressing Whole Health in Medicare Advantage Act--Supplemental Benefits for chronically Ill enrollees S. 3573--Medicare Advantage Supplemental Benefits Transparency Act--Improving Supplemental Benefits for MA beneficiaries HR 3514--To amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans--Prior Authorization in Medicare Advantage S 1816--A bill to amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans-Prior Authorization in Medicare Advantage H.R. 9393--Lower Costs, More Transparency Act of 2026--Promotes price transparency across hospitals, Ambulatory Surgical Centers (ASCs), and the broader health care sector H.R. 9392--Medicare Advantage Cost Transparency Act--An act to require MA plans and commercial plans to publicly post PA approval/denial rates, appeal outcomes, and average determination timelines H.R. 9395--Transparency in Medicare Advantage Steering Act--Statutory caps on compensation paid by MA organizations to agents and brokers H.R. 9544--Saving MEDICARE Act of 2026--To amend title XVIII of the Social Security Act to ensure appropriate payments under Medicare Advantage, and for other purposes. H.R.8163--Provider Reimbursement Stability Act of 2026--Medicare physician payment reform and Alternative Payment Model (APM) incentives H.R. 8375--Medicare Advantage Improvement Act--Prior authorization reform, plan transparency, prompt pay, and coverage standards alignment H.R. 9397--Premium Transparency Act--Requires MA plans to publish overhead costs, claims payment data, and MLR revenue detail H.R. 9396-Prior Authorization Accountability Act--Public posting of PA approval/denial rates, appeal outcomes, and processing times H.R. 9693--Patients First Act--Physician Fee Schedule reform H.R. 9645--Health Care Price Certainty for All Americans Act--Price transparency reform Health CARE Act of 2026--Reverse health care provisions from H.R. 1

Client expense: $290,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HJRes 197 / SJRes 197, CRA related to the 2027 NBPP; HR 247 / S 46, Health Care Affordability Act; HR 6867 / S 3562, the NIH Clinical Trial Integrity Act; HR 3521 / S 4440, the Clinical Trial Modernization Act; HR 4710 / S 2420, No Surprises Act Enforcement Act; HR 5526 / S 1954, Biosimilar Red Tape Elimination Act; HR 5582 / S 2355, the Patients Deserve Price Tags Act; HR 6248 / S 4027, Healthy Competition for Better Care Act HR 6485 / S 43, Skinny Labels, Big Savings Act; HR 6867 / S 3562, NIH Clinical Trial Integrity Act; HR 7895, the PBM Kickback Prohibition Act; HR 8879 / S 4509, Patients Before Monopolies Act; HR 8908, the STOP GAMES Act; HR 9393, Lower Costs, More Transparency Act; HR 9396, the Prior Authorization Accountability Act; HR 9397, the Premium Transparency Act; HR 9645, the Health Care Price Certainty for All Americans Act; HR 9661 / S 1414, the Expedited Access to Biosimilars Act; HR 10370, the AIM to Cure Kids with Cancer Act; HR 10788, the Lower Premiums, Faster Payments Act; S 976, the Insurance Fraud Accountability Act; S 1041, Affordable Prescriptions for Patients Act; S 1095, Stop STALLING Act; S 1096, Preserve Access to Affordable Generics & Biosimilars Act S 1097, Interagency Patent Coordination & Improvements Act; S 2658, Medication Affordability & Patent Integrity Act; S 3014, Ensuring Timely Access to Generics Act; S 3822, the Break Up Big Medicine Act Policies to address the expiration of the enhanced Advanced Premium Tax Credits; Policies to improve transparency in hospital and insurer costs and finances; Policies to streamline pediatric patient access to subspecialist care via telemedicine; Policies to protect patients and consumers from junk insurance, including short-term limited duration insurance; Policies related to modernization of clinical trials; Policies related to the 2027 FDA user fee agreements; Implementation of the No Surprises Act; Policies related to oversight of insurance agents and brokers; Oversight and patient impact of the 340B program; Policies related to consolidation within the healthcare sector;

Client expense: $120,000 · Firm income: Not reported

Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.

Client expense: Not reported · Firm income: $110,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The IBEW lobbied on provider payment and surprise medical bills issues raised by the No Surprises Enforcement Act (S. 2420 and H.R. 4710) The IBEW lobbied on ERISA preemption issues and other issues raised in the Patients Deserve Price Tags Act (S. 2355), the Health Care Price Certainty for All Act (H.R. 9645), as well as DOC Access Act (H.R. 1521), dealing with payment structures for optometrists and dentists.

Client expense: $200,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to site neutrality. Issues related to provider and insurer payment transparency. S.1629 - Same Care, Lower Cost Act. Issues related to Patients Deserve Price Tags Act (S.2355/H.R.5582). Issues related to Lower Costs, More Transparency Act of 2026 (H.R.9393). Issues related to Health Care Price Certainty for All Americans Act (H.R.9645).

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 2355/H.R. 5582; Patients Deserve Price Tags Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S.2276/ H.R. 3269; Eliminating Thickets to Improve Competition Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 1095; Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act S. 1096; Preserve Access to Affordable Generics and Biosimilars Act S. 1097; Interagency Patent Coordination and Improvements Act of 2025 S. 1414; Expedited Access to Biosimilars Act S. 2617; Reducing Drug Prices for Seniors Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S. 3349; PBM Disclosure Act S. 3549; PBM Fiduciary, Accountability, Integrity, and Reform Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 S. 5586; Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 2214; Delinking Revenue from Unfair Gouging Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 4570; Interagency Patent Coordination and Improvements Act of 2025 H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 6837; To amend the Employee Retirement Income Security Act of 1974 to ensure that pharmacy benefit managers are considered fiduciaries, and for other purposes. H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services oSec. 6702- Full Rebate Pass Through to Plans H.R. 7895; PBM Kickback Prohibition Act H.R. 8324; Great American Healthcare Plan H.R. 9228; Health Data Access, Transparency, and Affordability Act of 2026 H.R. 9486; Health Data Access, Transparency and Affordability Act H.R. 9117; Clear Healthcare Expense Cost Knowledge Act H.R. 9393; Lower Cost, More Transparency Act of 2026 H.R. 9645; Health Care Price Certainty for All Americans Act H.R. 10369; Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

Client expense: $3,203,049 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA)

S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S.4509/ H.R. 8779; Patients Before Monopolies Act S. 526; Pharmacy Benefit Manager Transparency Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3822; Break Up Big Medicine Act S. 4189; INSLUN Act of 2026 S. 5586; Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 1244; Reducing Drug Prices for Seniors Act H.R. 4317; PBM Reform Act H.R. 4409; Fair Pharmacies for Federal Employees Act H.R. 6610; Pharmacists Fight Back Act in the Federal Employees Health Benefits Program H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 9645; Health Care Price Certainty for All Americans Act H.R. 10369; Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

Client expense: $3,203,049 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE

S.1637/H.R 7871; Medicaid VBPs for Patients Act S. 2426/H.R. 3164; Ensuring Community Access to Pharmacist Services Act S. 2617/H.R. 1244; Reducing Drug Prices for Seniors Act S. 882; Patients Before Middlemen Act S. 927; Protecting Pharmacies in Medicaid Act S. 1041; Affordable Prescriptions for Patients Act S. 2800; Pharmacy and Medically Underserved Areas Enhancement Act S. 3345; PBM Price Transparency and Accountability Act S.4323/ H.R. 8143; Ensuring Access to Lower-Cost Medicines for Seniors Act of 2026 S. 5586; Ensuring Accurate Payments to Specialty Pharmacies Act H.R. 4317; PBM Reform Act H.R. 6609; Pharmacists Fight Back Act in Medicare and Medicaid H.R. 7148; Consolidated Appropriations Act of 2026 oSec. 6233- Any Willing Pharmacy oSec 6224- Medicare Delinking oSec. 6701- Oversight of PBM Services H.R. 9393; Lower Costs, More Transparency Act H.R. 9645; Health Care Price Certainty for All Americans Act H.R. 10369; Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 Implementation of the Inflation Reduction Act of 2022, P.L. 169- Provisions on Medicare Part D modernization and drug price negotiation, and the implementation of the Consolidated Appropriations Act of 2026 (P.L. 119-75)

Client expense: $3,203,049 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE

H. Res 1519 - Supporting the Designation of September 17, 2026 as National Physician Suicide Awareness Day to Raise Awareness of, and promote a national discussion about, physician suicide and to reduce the stigma of mental health conditions, and for other purposes. H. Res. 1528 - Recognizing Suicide as a serious public health problem and expressing support for the designation of September 2026 as National Physician Suicide Prevention Month, as well as September 10, 2026 as World Suicide Prevention Day. H.R. 1 - One Big Beautiful Bill Act, provisions relating to artificial intelligence (AI), provisions related to changes in medicaid regarding "Release the Pressure" hypertension control campaign H.R. 1254 - Rural Obstetrics Readiness Act, all provisions H.R. 2314 - Fair Access In Residency (FAIR) Act, all provisions H.R. 3492 - Protect Children's Innocence Act, all provisions H.R. 9390 - Prices on the Wall Act, all provisions H.R. 9395 - Transparency in Medicare Advantage Steering Act, all provisions H.R. 9645 - Health Care Price Certainty for All Americans Act, all provisions H.R. 9693 - The Patients First Act of 2026 - all provisions H.R.10444 - The Stop Corporate Takeovers of Physicians Act, all provisions H.R.1520 - Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions H.R.2191 - Physician Led and Rural Access to Quality Care Act, all provisions H.R.2332 - SHARE Act of 2025, all provisions H.R.2483 - SUPPORT for Patients and Communities Reauthorization Act of 2025, all provisions H.R.2850 - Youth Sports Facilities Act of 2025, all provisions H.R.3022 - Restoring Rights of Physicians to Own Hospitals Act, all provisions H.R.3164 - Ensuring Community Access to Pharmacist Services Act, all provisions H.R.3170 - Improving Access to Workers Compensation for Injured Federal Workers Act of 2025, all provisions H.R.4583 - Living Donor Protection Act of 2025, all provisions H.R.4710 - No Surprises Act Enforcement Act, all provisions H.R.5199 - Modernizing Rural Physician Assistant and Nurse Practitioner Utilization Act of 2025, all provisions H.R.5861 - Legacy Act of 2025, all provisions H.R.628 - Honor Our Living Donors Act, all provisions H.R.7023 - Affordable CHOICE Act, all provisions H.R.7868 - Expanding Support for Living Donors Act of 2026, all provisions H.R.7884 - Healthcare is Human Act of 2026, all provisions H.R.8794 - FED UP with Bleeding Disorders Act of 2026, all provisions H.R.9192 - Prior Authorization Reform for Autoimmune and Blood Disorders Act, all provisions H.R.929 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions H.R.9393 - Lower Costs, More Transparency Act of 2026, all provisions H.R.9396 - Prior Authorization Accountability Act, all provisions S. 380 - Rural Obstetrics Readiness Act, all provisions S.1390 - Physician Led and Rural Access to Quality Care Act, all provisions S.1419 - Youth Sports Facilities Act of 2025, all provisions S.1552 - Living Donor Protection Act of 2025, all provisions S.1782 - Charlotte Woodward Organ Transplant Discrimination Prevention Act, all provisions S.2355 - Patients Deserve Price Tags Act, all provisions S.2420 - No Surprises Act Enforcement Act, all provisions S.2426 - Equitable Community Access to Pharmacist Services , all provisions S.266 - Dr. Lorna Breen Health Care Provider Protection Reauthorization Act, all provisions S.3097 - Health Information Privacy Reform Act, all provisions S.3315 - Health Care Cybersecurity and Resiliency Act of 2026, all provisions S.3599 - Affordable CHOICE Act, all provisions S.3907 - Health Information Privacy Reform Act, all provisions S.5419 - The Stop Corporate Takeovers of Physicians Act, all provisions S.5496 - Health for the Commonwealth through Affordability Reform and Expansion Health Care (CARE) Act, all provisions "Legitimate Medical Purpose" definition under the Controlled Substance Act "Still at Risk" wristband initiative Jeanette Acosta Invest in Women's Health Act Comment Letter: [ACF-2026-0595] Reducing Federal Burden for Head Start Programs Comment Letter: [CMS-2026-1255-0001] Medicare and Medicaid Programs: Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, etc. Comment Letter: [REG-118484-25; CMS-9879-P; RIN 0938-AV94; RIN 1210-AC40; RIN 1545-BS02] Excepted Fertility Benefits Comment Letter: Request for Information (RFI) on Health Coverage that Works for Everyone Comment Letter: [2120-AM18] Improving Emergency Medical Kit Efficacy and Flexibility in Commercial Airline Operations Draft: Health Infrastructure Security and Accountability Act Draft: Noncompete clauses in physician contracts Matters related to AI use in prior authorization Matters related to Alternative Payment Model bonuses/incentive payments and freezing the qualifying provider revenue thresholds Matters related to Data privacy, cybersecurity, and AI Matters related to Health care consolidation Matters related to the Health Insurance Portability and Accountability Act (HIPAA) and electronic records Matters related to Maternal health and hypertensive disorder during pregnancy Matters related to Medical devices Matters related to Nutrition Matters related to the Office of the National Coordinator for Health Information Technology (ONC) improving electronic health record certification; implementation of 21st Century Cures Act provisions; digital health policies, and reduction of technology burden on physicians entering into the Quality Payment Program Matters related to Payment for AI services within health care Matters related to the Public Health effects of opioid medications Matters related to Unbundling of Maternity Care of Current Procedural Terminology (CPT) Codes Matters related to the United States Preventive Services Task Force (USPSTF) Matters related to Vaccines/ACIP Matters related to ACA benefits and payments Matters related to high-resolution anoscopy services Matters related to peptides Matters related to physician prescribing of antibiotics Matters related to reproductive health Matters related to the Authorization of ENDS Products Age Verification

Client expense: $4,540,000 · Firm income: Not reported

Government targets: Administration for Children & Families (ACF), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, Treasury, Dept of

- Corresponded with a member of the Missouri congressional delegation health staffer to distribute the CY2026 vs CY2027 proposed Medicare OPPS update. - Corresponded with members of the Missouri congressional delegation health staffers regarding CMS 340B actions. - Corresponded with members of the Missouri congressional delegation health staffers regarding access to CLFS for required certification deadline of July 31. - Corresponded with members of the Missouri congressional delegation health staffers to convene in-person meetings with Missouri congressional members. - Corresponded with a member of the Missouri congressional delegation health staffer to discuss Medicare Physician Fee Schedule update for CY 2027. - Corresponded with a member of the Missouri congressional delegation health staffer to distribute a copy of the Missouri Hospital Association comment letter to CMS regarding CY 2027 OPPS. - Corresponded with a member of the Missouri congressional delegation to thank congressman for introduction of H.R. 10394. - Corresponded with a member of the Missouri congressional delegation health staffer to discuss CMS proposed 340B changes. - Corresponded with a member of the Missouri congressional delegation health staffer regarding a comment letter to CMS on EMS/GEMT. - Corresponded with a member of the Missouri congressional delegation health staffer regarding the agreement between HRSA and pharmaceutical manufactures called Pharmaceutical Pricing Agreement. - Corresponded with a member of Health and Human Service to convene an in-person meeting to tour a local Missouri hospital. - Corresponded with a member of the Missouri congressional delegation health staffer to discuss a sign-on letter against Eli Lillys 340B action. - Corresponded with a member of the Missouri congressional delegation health staffer to discuss W&M markup. - Corresponded with a member of the Missouri congressional delegation health staffer to discuss H.R. 9645. - Corresponded with members of the Missouri congressional delegation health staffers to discuss HRSA 340B RFI comment letter. - Convened a virtual meeting to update Missouri congressional delegation health staffers on current hospital and health care issues. - Convened in-person meetings in Washington, DC with members of the Missouri congressional delegation and/or health staffers to discuss current hospital and health care issues.

Client expense: $97,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislation and regulation related to health care delivery and health insurance coverage, mental health and substance use disorder care and coverage and electronic health information/technology. Health coverage and issues related to H.R.7148 - Consolidated Appropriations Act, 2026 (PL 119-75) H.R.6248, S.4027 - Healthy Competition for Better Care Act S.3822 - Break Up Big Medicine Act H.R. 5582, S. 2355 - Patients Deserve Price Tags H.R. 9393 - Lower Costs, More Transparency Act H.R. 9504 - Tax Exempt Hospital Transparency Act Issues related to the Centers for Disease Control, public health, and health research Issues related to value-based care H.R. 9645 - Health Care Price Certainty for All Americans Act

Client expense: $500,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to reimbursement and coverage for clinical laboratory services, including the Medicare clinical laboratory fee schedule; implementation of the Protecting Access to Medicare Act (P.L. 113-93) and the Consolidated Appropriations Act, 2026 (P.L. 119-75); RESULTS Act (H.R. 5269/S. 2761); diagnostic regulatory reform; Enhancing CLIA Act (H.R. 8990); laboratory services as Essential Health Benefits; Patients Deserve Price Tags Act (H.R. 5582/S. 2355); Lower Costs, More Transparency Act (H.R. 9393); Health Care Price Certainty for All Americans Act (H.R. 9645); Prices on the Wall Act of 2026 (H.R. 9390).

Client expense: $850,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R.8163 - To amend title XVIII of the Social Security Act to ensure stability for provider payments under the Medicare program S.4254 - A bill to amend the Public Health Service Act to provide for a health care workforce innovation program. S.4109 - A bill to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes S.4110 - A bill to revise and extend health workforce programs under title VII of the Public Health Service Act H.R.7961 - Physicians and the Healthcare Workforce Act S.4086 - A bill to establish protections for health care providers who raise concerns about the quality of health care services, and for other purposes S.4039 - Professional Degree Access Restoration Act H.R.7884 - To amend the Internal Revenue Code of 1986 to provide a tax credit to health care professionals that provide health care services in qualifying facilities, and for other purposes; S.3908 - SOS: Sustaining Outpatient Services Act H.R.7686 - To recognize the importance of clinical roles of locum tenens physicians, and for other purposes H.R.7520 - Efficiency Adjustment Delay Act S.3762 - Prior Authorization Relief Act H.R.7118 - Genomic Answers for Childrens Health Act H.R. 1, the One Big, Beautiful Bill Act Improving seniors' timely access to care act (S. 1816 / H.R. 3514) Genomic Data Protection Act Tariffs PAMA reform S 1399, the Health Tech Investment Act H.R. 3580, the Oversight of Medicare Billing Code Cost Act S. 1916 - Protect Genetic information after bankruptcy S 1830 - HHS has no authority to regulate the practice of medicine LCD legislation HR2389/S1302 - Resident Physician Shortage Reduction Act S2333 - Public Health Workforce Loan Repayment Act S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act CLIA Waiver CURES 2.0 To prevent across-the-board direct spending cuts HR 5392, the Timely Access to Coverage Decisions Act of 2023 Remote digital telepathology HR 4527 - HEALTH DATA Act Primary Care and Health Workforce Expansion Act Gene Therapy HR 6371 - budget neutrality bill S. 1546/H.R. 3152 The Patent Eligibility Restoration Act Cures 2.1 S. 4935, Physician Fee Stabilization Act Medical Lab Personnel Shortage Relief Act S. 1380 - SPARC Act S. 942/H.R. 2028 - REDI Act H.R. 879 - Medicare Patient Access and Practice Stabilization Act of 2025 Issues relating to regulation of laboratory diagnostics CDC Division of Cancer Prevention and Control and cancer registries appropriations S. 2439 and H.R. 4731, Resident Physician Shortage Reduction Act H.R.5371 - Continuing Appropriations and Extensions Act, 2026 S 2420 / H.R. 4710 - No Surprises Act Enforcement Act S 2793 - Ensuring Access to Essential Providers Act of 2025 H.R. 5582 / S 2355 - Patients Deserve Price Tags Act Issues related to public health Conrad 30 Physician Workforce Optimization Act (S. 4637) H.R.9645 - Health Care Price Certainty for All Americans Act H.R. 9693 - The Patients First Act S 5180 Provider Reimbursement Stability Act S 5062 - FAIR DME Appeals Act H.R. 8500 / S. 5745 - Timely Access to Coverage Decisions Act ROOT Act HR 8890 the Enhancing CLIA Act

Client expense: $203,130 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Affordable Care Act and Extending Enhanced APTCs (H.R. 247; S. 46), Individual Market/ACA exchanges; Fraudulent Enrollments in Qualified Health Plans (S. 976, HR 2079), Behavioral Health, Employer-Provided Health Coverage; Surprise Billing (S. 2420, H.R. 4710); Cybersecurity; Health IT, Health Care Innovation, Transparency & PBMs (S. 891, H.R. 6703), PBM Compensation (H.R. 7895), Prescription Drugs (S. 1954, S. 1096, S.1040), Price Transparency (S. 2355, H.R. 9393, H.R. 9397, H.R. 9645, H.R. 9390), Prior Authorization (H.R. 9396), 340B, Insulin (S. 4189), Corporate Practice of Medicine, Anticompetitive Contracting (H.R. 6248, S. 4027).

Client expense: $670,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Expressed support for Section 340B of the Public Health Service Act. Urged Congress to revise Section 2 in line with concerns expressed over discussion draft on rebate conditions; that the current HRSA standard of additional definitions in Section 4 remain in place; that Section 8 recognize that child sites operated through other appropriate affiliated structures, in addition to wholly owned facilities, align compliance requirements with existing Medicare provider-based standards, and reconsider the proposed charity-care and Medicaid/CHIP revenue benchmarks to account for state and community variation. (H.R. 9393) - The Lower Costs, More Transparency Act of 2026 and (H.R. 9390) - The Prices on the Wall Act of 2026 - Urged Congress to ensure that any new transparency requirements are aligned with existing federal rules, avoid duplication, recognize the complexity of health care pricing, and provide sufficient flexibility for hospitals serving diverse communities and patient populations. (H.R. 9645) - The Health Care Price Certainty for All Americans Act - Urged Congress to ensure that any new transparency requirements are aligned with existing federal rules, avoid duplication, recognize the complexity of health care pricing, and provide sufficient flexibility for hospitals serving diverse communities and patient populations. (S.2372/H.R.4581) - 340B PATIENTS Act of 2025-Expressed support for the 340B Patients Act. This legislation would codify 340B providers' ability to use contract pharmacies to dispense 340B discounted drugs, ensure that 340B patients can pick up their prescriptions at any local pharmacy, and allow safety-net providers to continue providing expanded medical and social services to their communities using their 340B discount savings. (S. 2287/H.R. 4425) - Palliative Care and Hospice Education and Training Act (PCHETA) - Expressed support for the Palliative Care and Hospice Education and Training Act (PCHETA). This legislation would increase the number of permanent faculty in palliative care in medical schools, nursing schools, and other programs, promote education and research in palliative care and hospice, and support the development of faculty careers in academic palliative and hospice (S. 380) - Rural Obstetrics Readiness Act - Expressed support for the Rural Obstetrics Readiness Act. This bipartisan legislation would ensure that rural health care facilities are equipped with targeted resources to provide high-quality obstetric care to women within their own communities.

Client expense: $116,445 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), President of the U.S., SENATE

Healthcare issues related to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; H.R. 5582/S. 2355, the Patients Deserve Price Tags Act, H.R. 9393, the Lower Costs, More Transparency Act, and H.R. 9645, the Health Care Price Certainty for All Americans Act, provisions relating to lab test price transparency; H.R. 9117, the Clear Healthcare Expense Cost Knowledge (CHECK) Act, provisions relating to administrative service provider price transparency and itemized patient billing; S. 3097, the Health Information Privacy Reform Act, provision relating to privacy of health data; H.R. 8500, the Timely Access to Coverage Decisions Act, provisions relating to establishment of standards for Medicare local coverage decisions; H.R. 8890, the Enhancing Clinical Laboratory Innovation and Access (Enhancing CLIA) Act, provisions relating to oversight of laboratory-developed tests; H.R. 6130/S. 3267, the Alzheimers Screening and Prevention (ASAP) Act, provisions relating to Medicare coverage of blood-based dementia screening tests; H.R. 5444, the Medical Laboratory Personnel Shortage Relief Act, provisions relating to amending the Public Health Service Act to address the shortage of medical laboratory personnel; Federal policy relating to prior authorization and oversight of laboratory benefit managers; Federal policy relating to access to mandatory code sets for administrative transactions; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.

Client expense: $250,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Physician-Owned Hospitals including H.R. 2191 - Physician Led and Rural Access to Quality Care Act; H.R. 3022 - Restoring Rights of Physicians to Own Hospitals Act - re: physician self-referral to physician owned hospitals H.R. 9645 - Health Care Price Certainty for All Americans Act; H.R. 9393 - Lower Costs, More Transparency Act; H.R. 9390 - Prices on the Wall Act; H.R. 5582/S. 2355 - Patients Deserve Price Tags Act - re: hospital price transparency requirements and facility fees and ownership reporting requirements Health Care Affordability / Insurer Practices - re: federal policies impacting patient out-of-pocket costs, premium increases, medical loss ratio (MLR) requirements, and insurer transparency, including vertically integrated plan practices 340B Drug Pricing Program re: reporting drug acquisition costs Fair Treatment in Medical Debt Collections Act - re: medical debt collection requirements H.R. 1127/S. 4208 - Rural America Health Corps Act - re: workforce Health plan compliance with the H.R. 4710 No Surprises Act Enforcement Act independent dispute resolution process H.R. 3020 - Addressing Anti-Competitive Health Care Contract Clauses Act re: reform of health care contractual provisions

Client expense: $710,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The IBEW lobbied on provider payment and surprise medical bills issues raised by the No Surprises Enforcement Act (S. 2420 and H.R. 4710) The IBEW lobbied on ERISA preemption issues and other issues raised in the Patients Deserve Price Tags Act (S. 2355), the Health Care Price Certainty for All Act (H.R. 9645), as well as the FAIR Act (H.R. 6837), dealing with fiduciary standards for health plan trustees.

Client expense: $170,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE